Influx Healthtech Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹20(20.83%)
Premium (ELP)
Having completed its public offering, Influx Healthtech Limited's is now listed and trading on the NSE exchange as of Jun 25, 2025. The IPO raised cumulative capital of 61,00,800 Shares, including 50,00,400 Shares in primary capital infusion and ₹10.56 Cr in secondary market transactions.
The IPO was conducted with a price range of ₹91 to ₹96 and minimum investment requirement of 1200 shares. subscription activity between Jun 18, 2025 and Jun 20, 2025 reflected market assessment of the offering's valuation and prospects.
The allotment process finalized on Jun 23, 2025 distributed equity ownership to successful bidders. The listing established a transparent market mechanism for share trading, price discovery, and investor participation in the company's future growth.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Influx Healthtech Limited, established in September 2020, is a healthcare-focused company that provides contract manufacturing services. It operates as a trusted CDMO (Contract Development and Manufacturing Organization), serving clients across various sectors. The company runs three manufacturing units located in Thane, Maharashtra, with facility sizes of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its product range includes tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules, candies, gym and sports supplements, as well as skincare, body care, hair care, beard care products, face masks, and soaps. It also manufactures ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company supports nutraceutical and cosmetic businesses by handling the entire process from product development to manufacturing and regulatory assistance, allowing clients to concentrate on formulation and market launch. As of June 11, 2025, Influx Healthtech Limited employs 163 full-time staff members.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Wide Product Range – Offers products in pharma, nutraceuticals, and cosmetics
- Trusted Client Base – Strong relationships with well-known health and wellness brands
- Strong Quality Control – Follows GMP, FSSAI, and other standards with strict quality checks
- High Competition – Competes with big CDMO players like Jubilant and Divi’s Labs
- Raw Material Price Fluctuations – Changing input costs can reduce profit margins
- Dependence on Key Clients – Losing major customers could impact business stability.
- Mr. Munir Abdul Ganee Chandniwala
- Mrs. Shirin Munir Ahmed Chandniwala
- Mr. Abdul Ganee Abdul Rasul Chandniwala
Influx Healthtech Limited
Maashitla Securities Private Limited